.
Phylogica Limited (ASX:PYC) has raised $2.15 million through a share placement, just days after announcing it has completed the first stage of collaboration with the world's largest drugmaker, Pfizer Inc. (NYSE:PFE).
The peptide drug discovery company raised the funds through a placement to institutional and sophisticated investors at an issue price of $0.053 per share.
Phylogica plans to put the funds to enhancing its drug discovery infrastructure, investing in in-house programmes and supporting operational activities.
Earlier this week Phylogica announced it will receive its first milestone payment, for an undisclosed amount, from a collaboration with Pfizer to discover novel peptide-based vaccines.
The company currently has partnerships with Roche, Pfizer and MedImmune and is aiming to secure three new alliances by the end of fiscal 2012.
Phylogica reported a net loss of $3.6 million in the 2011 financial year.
{"streaming_server":"rtmp:\/\/s2svek4dh1hfyu.cloudfront.net\/cfx\...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |